Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

ERT Unveils Full Range of ePRO Solutions Providing the Power of Choice for Clinical Trial Sponsors

December 16, 2010 6:31 am | by RealWire | News | Comments

PHILADELPHIA, PA, 16 December 2010 ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of its comprehensive suite of electronic patient-reported outcome (ePRO) solutions. As the ePRO market...

NOVAVAX Receives FDA Clearance to Launch Phase I RSV Vaccine Clinical Trial

December 16, 2010 5:31 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Dec. 16, 2010 /- Novavax, Inc. (Nasdaq: NVAX ) announced today that the company's Phase I clinical trial to evaluate a new vaccine candidate to prevent respiratory syncytial virus (RSV) infection has been cleared by the U.S. Food and Drug Administration (FDA) and is no...

New research finds delaying surgical procedures increases infection risk and health care costs

December 15, 2010 1:31 pm | by EurekAlert | News | Comments

(Weber Shandwick Worldwide) Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the...

Advertisement

Novel therapy for metastatic kidney cancer developed at VCU Massey Cancer Center

December 15, 2010 7:32 am | by EurekAlert | News | Comments

(Virginia Commonwealth University) Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the...

Amira Pharmaceuticals Announces the Nomination of an Orally Available Pre-Clinical Candidate in a New LPA-Related Program, an Autotaxin Inhibitor

December 15, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Dec. 15, 2010 /- Amira Pharmaceuticals, Inc. announced today that it has successfully identified a novel pre-clinical candidate for its newest lysophosphatidic acid (LPA)-related program, autotaxin.  Autotaxin is an enzyme upstream from LPA receptors and has been...

SMD Platinum RTD Temperature Sensor Suited for Biomedical Applications

December 15, 2010 5:45 am | Heraeus Sensor Technology USA | Product Releases | Comments

Heraeus Sensor Technology has introduced a surface mount platinum RTD temperature sensing element uniquely suited for use in biomedical applications.

Accuray Receives FDA Clearance for the CyberKnife® System's Lung Optimized Treatment

December 15, 2010 5:31 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Dec. 15, 2010 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market Lung Optimized Treatment, a new component of the...

New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment

December 13, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Dec. 13, 2010 /- Masimo (Nasdaq: MASI ) announced today that a new clinical study demonstrating the accuracy of its latest medical technology breakthrough— Rainbow Acoustic Monitoring™ —was presented last week at the American Association of Respiratory...

Advertisement

Apartment-dwelling children in nonsmoking units still exposed

December 12, 2010 10:31 pm | by EurekAlert | News | Comments

(University of Rochester Medical Center) Children living in apartments are exposed to secondhand smoke even when no one smokes inside their own unit. This study, released online today by the journal Pediatrics, strongly suggests that housing type contributes to children's exposure to...

High CTC Levels Predicted Poor Outcome in Metastatic Breast Cancer

December 10, 2010 9:31 am | by AACR | News | Comments

SAN ANTONIO - A high level of circulating tumor cells (CTCs) - cells that have detached from a tumor and are circulating in the body through the blood - are an independent prognostic marker in metastatic breast cancer as first-line therapy. In addition, persistence of high CTC level...

Mylan Receives Approval for Generic Version of Adalat® CC Tablets

December 10, 2010 5:32 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Dec. 10, 2010 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nifedipine Extended-release Tablets USP,...

Tomophase OCTIS(TM) Receives FDA 510(K) Clearance to Market

December 10, 2010 5:31 am | by Bio-Medicine.Org | News | Comments

BURLINGTON, Mass., Dec. 10, 2010 /- Tomophase Corporation, developer of the non-invasive Optical Coherence Tomography Imaging System (OCTIS™) and other devices, announced today that it has received FDA 510(k) clearance to market OCTIS. Tomophase is a leader in the development of OCT...

Covidien Announces the Launch of Three New Platforms for its Puritan Bennett(TM) 840 Ventilators

December 9, 2010 4:34 pm | by Covidien | News | Comments

Puritan Bennett(TM) 840 Neonatal, Universal and Pediatric-Adult Ventilators Deliver Comprehensive Ventilation to a Broad Range of Patients BOULDER, Colo., Dec 09, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in...

Advertisement

New Surgeon General Report on Smoking and Disease Caps Successful Year of Federal Anti-Tobacco Action, AACR Says

December 9, 2010 1:32 pm | by AACR | News | Comments

WASHINGTON, D.C. - The American Association for Cancer Research commends the U.S. Office of the Surgeon General for its continued focus on tobacco, one of most pressing public health issues of our time. The Surgeon General today released a new report, How Tobacco Smoke Causes Disease,...

Cancer prevention expert honored for innovative tobacco research

December 9, 2010 11:32 am | by EurekAlert | News | Comments

(University of Texas M. D. Anderson Cancer Center) Behavioral scientist and tobacco-cessation expert, Alexander V. Prokhorov, M.D., Ph.D., at the University of Texas MD Anderson Cancer Center is the recipient of the 2011 American Society of Preventive Oncology Joseph W. Cullen Memorial...

New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations

December 9, 2010 5:32 am | by Bio-Medicine.Org | News | Comments

RIDGEFIELD, Conn., Dec. 9, 2010 /- Boehringer Ingelheim Pharmaceuticals, Inc. announced that new data from a subgroup analysis of the phase IIb/III LUX-Lung 1 trial show that afatinib (BIBW 2992) reached a four-fold extension (4.4 months vs. 1.0 month for placebo) in progression-free...

Developing robots for the hospital emergency room

December 7, 2010 5:34 pm | by EurekAlert | News | Comments

(Vanderbilt University) A group of computer engineers at Vanderbilt University is convinced that the basic technology is now available to create robot assistants that can perform effectively in the often-chaotic environment of the emergency room. The specialists in emergency medicine at...

Michael Jackson's Death Could Have Been Avoided With a Brain Monitor Says Anesthesiologist

December 7, 2010 4:34 am | by Bio-Medicine.Org | News | Comments

NEWPORT BEACH, Calif., Dec. 7, 2010 /- About 80 percent of the surgeries performed in the U.S. put patients at risk of being inflicted with delirium, dementia or death because a brain monitor is not used by the anesthesiologist. That is one of the secrets unveiled in a new book recently...

In the Treatment of COPD, Greater Use in the Primary Care Setting Will Strengthen Spiriva's Position Among Sales Leaders

December 6, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

BURLINGTON, Mass., Dec. 6, 2010 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Boehringer Ingelheim/Pfizer's Spiriva will most likely strengthen its position among the sales leaders for the treatment of...

Compumedics Home Sleep Testing System Selected for Use in US National Institute of Health (NIH)-Sponsored Multi-Ethnic Study of Atherosclerosis (MESA) Sleep Study

December 6, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

CHARLOTTE, N.C., Dec. 6, 2010 /- Compumedics USA, Inc. (CMP.ASX) today announced its new Somte® PSG portable sleep-testing systems were chosen as part of a major new study to further investigate the link between sleep disorders and cardio-vascular disease in various ethnic and racial...

NIH-sponsored panel issues comprehensive US food allergy guidelines

December 6, 2010 4:32 am | by EurekAlert | News | Comments

(NIH/National Institute of Allergy and Infectious Diseases) An expert panel sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has issued comprehensive US guidelines to assist health care professionals in diagnosing food...

Northern wildfires threaten runaway climate change, study reveals

December 5, 2010 9:33 am | by EurekAlert | News | Comments

(University of Guelph) This study reveals that fires in the Alaskan interior have become more severe in the last decade, resulting in more carbon being released than is being stored. About half the world's soil carbon is locked in northern permafrost and peatland soils. The increased...

CareFusion Launches Next-Generation Clinical Pulmonary and Cardiopulmonary Diagnostics Software

December 3, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Dec. 3, 2010 /- CareFusion (NYSE: CFN ), a leading, global medical device company, today announced the launch of SentrySuite, a new set of software applications that improve the quality of patient data and increase clinician productivity and efficiency in pulmonary and...

FDA Clears GeNO LLC's Investigational New Drug Application for Clinical Trials With Its NITROSYLâ„¢ Inhaled Nitric Oxide System

December 2, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

COCOA, Fla., Dec. 2, 2010 /- GeNO LLC ( www.genollc.com ), a privately held, advanced development-stage technology company, announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for a clinical trial with the GeNO...

Dawson James Initiates Research Coverage of Advanced Life Sciences

December 2, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

CHICAGO, Dec. 2, 2010 /- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS ), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading